Download PDF
Thorac Cardiovasc Surg
DOI: 10.1055/a-2141-8105
Original Cardiovascular

Determinants of Inadequate Cardioprotection in Adult Patients with Left Ventricular Dysfunction

Krzysztof Sanetra
1   Division of Cardiovascular Surgery, Andrzej Frycz Modrzewski Krakow University, Bielsko-Biała, Poland
2   Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland
,
Witold Gerber
2   Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland
3   Department of Cardiac Surgery, Academy of Silesia, Katowice, Poland
,
Piotr Paweł Buszman
4   Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland
5   Department of Cardiology, Andrzej Frycz Modrzewski Krakow Univeristy, Krakow, Poland
6   Department of Cardiology, American Heart of Poland, Bielsko- Biala, Poland
,
Marta Mazur
5   Department of Cardiology, Andrzej Frycz Modrzewski Krakow Univeristy, Krakow, Poland
,
Krzysztof Milewski
4   Center for Cardiovascular Research and Development, American Heart of Poland, Katowice, Poland
6   Department of Cardiology, American Heart of Poland, Bielsko- Biala, Poland
7   Department of Cardiology, Academy of Silesia, Katowice, Poland
,
Paweł Kaźmierczak
8   American Heart of Poland, Katowice, Poland
,
Andrzej Bochenek
2   Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland
3   Department of Cardiac Surgery, Academy of Silesia, Katowice, Poland
› Author Affiliations
› Further Information
    Permissions and Reprints All articles of this category

Abstract

Background Perioperative cardioprotection is essential for achieving satisfactory clinical outcomes in heart failure patients. It is important to understand the factors affecting perioperative cardioprotection.

Methods The institutional database was searched for patients with reduced ejection fraction (EF, < 40%) who underwent surgery with cardioplegia-induced arrest. Patients were divided into del Nido cardioplegia (DN) and cold blood cardioplegia (CB) groups. The relationships between age, preoperative blood parameters, creatinine, cross-clamp time (CCT), extracorporeal circulation time (ECT), and postoperative troponin values at 12 hours or deterioration of EF (≥5%) were evaluated. Baseline characteristics, operative parameters, and outcomes were analyzed.

Results There were 508 patients with reduced EF (331 DN and 177 CB). In the entire cohort, anemic patients had greater troponin values (p = 0.004) as well as in the DN group (p = 0.002). However, this was not detected in the CB group (flat regression line; p = 0.674). Patients with high leukocyte values had greater troponin release (entire cohort: p < 0.001; DN group: p < 0.001; CB group: steep regression line with p = 0.042). Longer CCT and ECT were associated with greater troponin release (entire cohort; both groups) and greater risk of fall in EF. In a direct comparison, fewer patients had significant deterioration of EF in the DN group than CB group (3.9 vs. 11.9%; p < 0.001).

Conclusion The use of CB cardioplegia may be beneficial in anemic patients, whereas the use of DN cardioplegia may be beneficial for expected long CCT and high leukocytosis.

Keywords

cardioprotection - cardioplegia - heart failure - cardiopulmonary bypass

Data Availability Statement

The article's data can be shared on reasonable request to the corresponding author.




Publication History

Received: 14 February 2023

Accepted: 25 July 2023

Accepted Manuscript online:
26 July 2023

Article published online:
29 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Flack III JE, Cook JR, May SJ. et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation 2000; 102 (19, Suppl 3): III84-III89
    PubMedGoogle Scholar
  • 2 Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 2012; 44 (03) 98-103 Erratum in: J Extra Corpor Technol 2013;45(4):262
    CrossrefPubMedGoogle Scholar
  • 3 Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM, Fitzgerald D. The use of del Nido cardioplegia in adult cardiac surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 2018; 155 (03) 1011-1018
    CrossrefPubMedGoogle Scholar
  • 4 Sanetra K, Gerber W, Shrestha R. et al. The del Nido versus cold blood cardioplegia in aortic valve replacement: a randomized trial. J Thorac Cardiovasc Surg 2020; 159 (06) 2275-2283.e1
    CrossrefPubMedGoogle Scholar
  • 5 Ucak HA, Uncu H. Comparison of del Nido and intermittent warm blood cardioplegia in coronary artery bypass grafting surgery. Ann Thorac Cardiovasc Surg 2019; 25 (01) 39-45
    CrossrefPubMedGoogle Scholar
  • 6 Wahba A, Milojevic M, Boer C. et al; EACTS/EACTA/EBCP Committee Reviewers. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg 2020; 57 (02) 210-251
    PubMedGoogle Scholar
  • 7 Follette DM, Mulder DG, Maloney JV, Buckberg GD. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. Experimental and clinical study. J Thorac Cardiovasc Surg 1978; 76 (05) 604-619
    CrossrefPubMedGoogle Scholar
  • 8 Thygesen K, Alpert JS, Jaffe AS. et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol 2018; 72 (18) 2231-2264
    CrossrefPubMedGoogle Scholar
  • 9 Aykut G, Ulugöl H, Aksu U. et al. Microcirculatory response to blood vs. crystalloid cardioplegia during coronary artery bypass grafting with cardiopulmonary bypass. Front Med (Lausanne) 2022; 8: 736214
    CrossrefPubMedGoogle Scholar
  • 10 Roth M, Kraus B, Scheffold T, Reuthebuch O, Klövekorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg 2000; 120 (04) 642-650
    CrossrefPubMedGoogle Scholar
  • 11 Onorati F, Santini F, Menon T. et al. Leukocyte filtration of blood cardioplegia attenuates myocardial damage and inflammation. Eur J Cardiothorac Surg 2013; 43 (01) 81-89
    CrossrefPubMedGoogle Scholar
  • 12 McCully JD, Toyoda Y, Wakiyama H, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide. Ann Thorac Surg 2006; 82 (01) 117-123
    CrossrefPubMedGoogle Scholar
  • 13 McCully JD, Rousou AJ, Parker RA, Levitsky S. Age- and gender-related differences in mitochondrial oxygen consumption and calcium with cardioplegia and diazoxide. Ann Thorac Surg 2007; 83 (03) 1102-1109
    CrossrefPubMedGoogle Scholar
  • 14 Willems L, Zatta A, Holmgren K, Ashton KJ, Headrick JP. Age-related changes in ischemic tolerance in male and female mouse hearts. J Mol Cell Cardiol 2005; 38 (02) 245-256
    CrossrefPubMedGoogle Scholar
  • 15 Balderman SC, Bhayana JN, Binette P, Chan A, Gage AA, Alder RH. Perioperative preservation of myocardial ultrastructure and high-energy phosphates in man. J Thorac Cardiovasc Surg 1981; 82 (06) 860-869
    CrossrefPubMedGoogle Scholar
  • 16 Magilligan Jr DJ, Vij D, Peper W, Allor D, Frinak S, Tilley B. Failure of standard cardioplegic techniques to protect the conducting system. Ann Thorac Surg 1985; 39 (05) 403-408
    CrossrefPubMedGoogle Scholar
  • 17 Quintilio C, Voci P, Bilotta F. et al. Risk factors of incomplete distribution of cardioplegic solution during coronary artery grafting. J Thorac Cardiovasc Surg 1995; 109 (03) 439-447
    CrossrefPubMedGoogle Scholar
  • 18 Hilton CJ, Teubl W, Acker M. et al. Inadequate cardioplegic protection with obstructed coronary arteries. Ann Thorac Surg 1979; 28 (04) 323-334
    CrossrefPubMedGoogle Scholar
  • 19 Goldman BS, Ovil Y, Mycyk T. A technique for selective graft perfusion during aortocoronary bypass. J Card Surg 1987; 2 (04) 495-498
    CrossrefPubMedGoogle Scholar
  • 20 Onem G, Sacar M, Baltalarli A, Ozcan AV, Gurses E, Sungurtekin H. Comparison of simultaneous antegrade/vein graft cardioplegia with antegrade cardioplegia for myocardial protection. Adv Ther 2006; 23 (06) 869-877
    CrossrefPubMedGoogle Scholar
  • 21 Yerebakan H, Sorabella RA, Najjar M. et al. Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg 2014; 9: 141
    CrossrefPubMedGoogle Scholar
  • 22 Gunaydin S, Gunertem OE, Babaroglu S, Kunt AT, McCusker K, Ozisik K. Clinical outcomes of single-dose cardioplegia in high-risk coronary bypass. Asian Cardiovasc Thorac Ann 2021; 29 (02) 77-83
    CrossrefPubMedGoogle Scholar